Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase

por Bilen, Ozlem, Ballantyne, Christie M.
Publicado 2016

Improving Outcomes After Myocardial Infarction in the US Population

por Kayani, Waleed T., Ballantyne, Christie M.
Publicado 2018

Ultrasound in Cardiovascular Risk Prediction: Don't Forget the Plaque!

por Nambi, Vijay, Brunner, Gerd, Ballantyne, Christie M.
Publicado 2013

Statin-Induced Diabetes: Will It Change Clinical Practice?

por Belalcazar, L. Maria, Raghavan, Vasudevan A., Ballantyne, Christie M.
Publicado 2009

Endothelial Domes Encapsulate Adherent Neutrophils and Minimize Increases in Vascular Permeability in Paracellular and Transcellular Emigration

por Phillipson, Mia, Kaur, Jaswinder, Colarusso, Pina, Ballantyne, Christie M., Kubes, Paul
Publicado 2008

The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis

por Chen, Suet Nee, Ballantyne, Christie M, Gotto, Antonio M, Marian, Ali J
Publicado 2009

PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance

por Jia, Xiaoming, Al Rifai, Mahmoud, Saeed, Anum, Ballantyne, Christie M, Virani, Salim S
Publicado 2022

Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade

por Phillipson, Mia, Heit, Bryan, Colarusso, Pina, Liu, Lixin, Ballantyne, Christie M., Kubes, Paul
Publicado 2006

Comparative associations of diabetes risk factors with five measures of hyperglycemia

por Poon, Anna K, Juraschek, Stephen P, Ballantyne, Christie M, Steffes, Michael W, Selvin, Elizabeth
Publicado 2014

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

por Bays, Harold E., Ballantyne, Christie M., Braeckman, Rene A., Stirtan, William G., Soni, Paresh N.
Publicado 2013

The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals

por Tumova, Eva, Sun, Wensheng, Jones, Peter H., Vrablik, Michal, Ballantyne, Christie M., Hoogeveen, Ron C.
Publicado 2013

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease

por Doody, Rachelle S., Demirovic, Jasenka, Ballantyne, Christie M., Chan, Wenyaw, Barber, Robert, Powell, Suzanne, Pavlik, Valory
Publicado 2015

Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ

por Mao, Hua, Lockyer, Pamela, Li, Luge, Ballantyne, Christie M., Patterson, Cam, Xie, Liang, Pi, Xinchun
Publicado 2017

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study

por Whelton, Seamus P., McEvoy, John W., Lazo, Mariana, Coresh, Josef, Ballantyne, Christie M., Selvin, Elizabeth
Publicado 2017

Correction to: Role of Bempedoic Acid in Clinical Practice

por Ballantyne, Christie M., Bays, Harold, Catapano, Alberico L., Goldberg, Anne, Ray, Kausik K., Saseen, Joseph J.
Publicado 2021

Role of Bempedoic Acid in Clinical Practice

por Ballantyne, Christie M., Bays, Harold, Catapano, Alberico L., Goldberg, Anne, Ray, Kausik K., Saseen, Joseph J.
Publicado 2021

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

por Ballantyne, Christie M., Bays, Harold E., Louie, Michael J., Smart, Jeremy, Zhang, Yang, Ray, Kausik K.
Publicado 2022

Elevated Plasma SPARC Levels Are Associated with Insulin Resistance, Dyslipidemia, and Inflammation in Gestational Diabetes Mellitus

por Xu, Lu, Ping, Fan, Yin, Jinhua, Xiao, Xinhua, Xiang, Hongding, Ballantyne, Christie M., Wu, Huaizhu, Li, Ming
Publicado 2013

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study

por Ballantyne, Christie M., Manku, Mehar S., Bays, Harold E., Philip, Sephy, Granowitz, Craig, Doyle, Ralph T., Juliano, Rebecca A.
Publicado 2019

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-...

por Brinton, Eliot A, Ballantyne, Christie M, Bays, Harold E, Kastelein, John J, Braeckman, Rene A, Soni, Paresh N
Publicado 2013